Serial #99752399
LIVE

Serial Number

99752399

Owner

Hugel, Inc.

Attorney

David Youngjoon Jung

First Use Date

Jul 30, 2024

Filing Date

Apr 8, 2026

Add to watchlist:

No watchlists yet
View on USPTO

Serial #99752399 Trademark

Serial Number: 99752399

Serial #99752399 is a trademark filed by Hugel, Inc. on April 8, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Hugel, Inc. (2 trademarks)

23, Geodudanji 1-gil, Dongnae-myeon
Chuncheon-si, Gangwon-do 24398 , KR

Entity Type: 99

Trademark Details

Filing Date

April 8, 2026

Registration Date

Not Registered

First Use Anywhere

July 30, 2024

First Use in Commerce

July 30, 2024

Goods & Services

Pharmaceutical preparations containing botulinum toxin; Pharmaceutical preparations for the treatment of wrinkles, containing botulinum toxin; Pharmaceutical preparations for the treatment of wrinkles, containing botulinum toxin fragments; Botulinum toxin for medical use for use in the treatment of excessive sweating, excessive eye blinking, neuropathy pain, facial wrinkles, headache, pain, spasm, dystonia, urogenital system diseases and conditions, skin disorders; Bacterial poisons; Pharmaceutical preparations for skin care; Pharmaceutical preparations used in cosmetic surgery; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for the treatment of spasm; Pharmaceutical preparations for the treatment of dystonia; Muscle relaxants; Pharmaceutical agents for epidermis; Biological preparations for the treatment of aesthetic dermatology, orthopaedics, arthritis and ophthalmology; Bacteriological preparations for medical and veterinary use; Adjuvants for medical purposes; Medicinal creams for skin care; Pharmaceutical preparations for the treatment of wrinkles; Therapeutic pharmaceutical for the treatment of excessive sweating, excessive eye blinking, neuropathy pain, facial wrinkles, headache, pain, spasm, dystonia, urogenital system diseases and conditions, skin disorders; Biological preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhidrosis and cerebral palsy; Biological preparations for the treatment of tremors, namely, spasmodic smooth, striated or cardiac muscles; Syringes sold filled with medical botulinum toxin as the main ingredient; Pharmaceutical preparations for the treatment of urogenital system diseases and conditions, namely, overactive bladder and urinary incontinence; Pharmaceutical preparations for the treatment of muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, tremors and pain; Pharmaceutical preparations for the treatment of hyperhidrosis; Pharmaceutical preparations for the treatment of peripheral nervous system; Pharmaceutical preparations for the treatment of central nervous system; Migraine treatment preparations

Filing History

APPLICATION FILING RECEIPT MAILED
Apr 8, 2026 MAFR
NEW APPLICATION ENTERED
Apr 8, 2026 NWAP